Amphetamine/Dextroamphetamine vs Lisdexamfetamine

Both medications are highly effective for ADHD symptoms. In clinical trials, lisdexamfetamine demonstrated significant improvements in ADHD Rating Scale (ADHD-RS) scores compared to placebo, with effect sizes comparable to mixed amphetamine salts ^[2][4].

Adderall XR provides approximately 10-12 hours of symptom coverage with a biphasic release profile (two pulses of medication) ^[1]. Adderall IR lasts approximately 4-6 hours and is often dosed 2-3 times daily ^[1]. Lisdexamfetamine provides up to 13-14 hours of symptom control with a smooth, single-phase absorption curve ^[2][4].

The SPD489-325 study directly compared lisdexamfetamine with mixed amphetamine salts XR and found comparable efficacy, with lisdexamfetamine showing a numerically longer duration of effect in the simulated classroom setting ^[4]. Both achieved robust effect sizes (d > 1.0) for ADHD symptom reduction.

Vyvanse also holds an FDA approval for moderate-to-severe binge eating disorder (BED) in adults, an indication Adderall does not have ^[2]. For patients with comorbid ADHD and BED, this dual indication makes lisdexamfetamine a logical choice.

Both medications share similar stimulant side effects due to their common amphetamine mechanism ^[1][2]. The most common adverse effects include decreased appetite (27-39%), insomnia (13-27%), dry mouth (4-26%), headache (12-21%), and irritability (10-12%) ^[1][2].

Cardiovascular effects are a class concern for all stimulants, including increased heart rate (typically 3-6 bpm) and blood pressure (2-4 mmHg systolic) ^[1][2]. Both carry FDA warnings about serious cardiovascular risks in patients with pre-existing structural cardiac abnormalities.

Lisdexamfetamine's prodrug mechanism provides a smoother pharmacokinetic profile, which may reduce the intensity of peak-dose side effects and end-of-dose rebound compared to Adderall IR ^[2][3]. Some patients report less evening appetite suppression and fewer mood swings with lisdexamfetamine.

Both are Schedule II controlled substances, but lisdexamfetamine has a lower potential for misuse because crushing or injecting the pill does not accelerate its conversion to active dextroamphetamine ^[3]. The prodrug must pass through gastrointestinal enzymes to become active, reducing its abuse liability.

Weight loss and growth suppression are concerns with long-term use of both medications in children and adolescents. Periodic drug holidays and growth monitoring are recommended ^[1][2].

Cost can differ substantially between these medications. Generic Adderall (both IR and XR) is widely available, typically costing $20-$60 per month depending on dose and formulation ^[5].

Generic lisdexamfetamine became available in the U.S. in August 2023, substantially reducing costs. Generic Vyvanse typically costs $30-$80 per month ^[5]. Prior to generic entry, brand Vyvanse cost $350-$400 per month.

Insurance coverage is generally good for both medications, though plans may require prior authorization for brand-name versions. Step therapy requirements sometimes mandate trying Adderall before covering lisdexamfetamine.

Adderall IR must be taken 2-3 times daily, which can be inconvenient and raises privacy concerns for school-age children who need midday doses ^[1]. Adderall XR and Vyvanse are both once-daily medications taken in the morning ^[1][2]. Vyvanse capsules can be opened and dissolved in water for patients who cannot swallow pills, maintaining the prodrug's controlled-release properties ^[2]. Vyvanse's consistent duration and smoother pharmacokinetic profile mean fewer end-of-day dosing decisions, which many patients and parents find more convenient.

The choice between Adderall and Vyvanse depends on individual response, duration of coverage needed, abuse risk considerations, and cost ^[1][2].

Vyvanse may be preferred for patients who need long-duration coverage (13+ hours), those with a history of or risk for stimulant misuse, and patients who experience rebound symptoms with Adderall ^[2][3]. Its approval for binge eating disorder adds value for patients with that comorbidity.

Adderall IR offers dosing flexibility — it can be taken as needed and dose timing can be adjusted throughout the day. Adderall XR provides a middle ground with 10-12 hours of coverage. The availability of low-cost generics for all Adderall formulations can be a deciding factor when cost is a concern ^[1][5].

Many clinicians start with one medication and switch if the response is inadequate or side effects are intolerable. Since both are amphetamine-based, cross-titration is relatively straightforward under medical guidance.

This information is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider.